MRD as Biomarker for Response to Donor Lymphocyte Infusion after Allogeneic Hematopoietic Cell Transplantation in Patients with AML.
Teich K, Stadler M, Gabdoulline R, Kandarp J, Wienecke C, Heida B, Klement P, Büttner K, Venturini L, Wichmann M, Puppe W, Schultze-Florey C, Koenecke C, Beutel G, Eder M, Ganser A, Heuser M, Thol F.
Teich K, et al. Among authors: venturini l.
Cancers (Basel). 2023 Aug 1;15(15):3911. doi: 10.3390/cancers15153911.
Cancers (Basel). 2023.
PMID: 37568726
Free PMC article.